# UPC (Universe Pharmaceuticals INC) - SEC EDGAR Financial Statements

> Universe Pharmaceuticals INC reported $17.86B in revenue and a net loss of $3.67B for the fiscal year ended September 30, 2025 (down 22.4% year over year), with a 35.3% gross margin and a -16.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/UPC
- Markdown: https://convexityos.com/fundamentals/UPC.md
- SEC CIK: 0001809616
- Reporting currency: USD
- Latest filing period: September 30, 2025
- Last synced: Nov 21, 2026, 05:13 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001809616&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $17.86B | -22.4% YoY |
| Operating Income | FY 2025 | -$2.92B | -16.3% margin |
| Net Income | FY 2025 | -$3.67B | -20.6% net margin |
| Diluted EPS | FY 2025 | -$8.06 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$5.32B | -29.8% FCF margin |
| Cash & ST Investments | Sep 30, 2025 | $33.59B | Total debt: $9.26B |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $17.86B | $23.02B | $32.31B | $40.14M | $47.98M | $30.70M | $33.23M |
| Cost of Revenue | $11.56B | $16.95B | $21.99B | $18.25M | $22.66M | $16.61M | $19.82M |
| **Gross Profit** | $6.30B | $6.07B | $10.32B | $21.89M | $25.33M | $14.09M | $13.41M |
| Research & Development | $671.8M | $3.03B | $4.86B | $7.64M | $5.47M | $583K | $618K |
| Selling, General & Admin | $8.55B | $11.06B | $9.42B | $21.27M | $6.27M | $3.26M | $3.04M |
| Total Operating Expenses | $9.22B | $14.09B | $14.28B | $28.91M | $11.74M | $3.84M | $3.65M |
| **Operating Income** | -$2.92B | -$8.02B | -$3.97B | -$7.02M | $13.59M | $10.25M | $9.75M |
| **EBITDA** | -$2.40B | -$7.53B | -$3.46B | -$6.49M | $14.04M | $10.66M | $10.17M |
| Interest Expense | $289.4M | $304.5M | $190.2M | $162K | $102K | $124K | $129K |
| Income Before Tax | -$3.67B | -$8.12B | -$4.33B | -$7.09M | $13.68M | $10.10M | $9.65M |
| Income Tax Expense | -- | $606.7M | $2.25B | $815K | $2.36M | $2.54M | $2.10M |
| **Net Income** | -$3.67B | -$8.73B | -$6.58B | -$7.91M | $11.32M | $7.56M | $7.55M |
| Basic EPS | -$8.06 | -$626.96 | -$1,089.21 | -$1,309.11 | $2,105.88 | $1,658.49 | $1,658.49 |
| **Diluted EPS** | -$8.06 | -$626.96 | -$1,089.21 | -$1,309.11 | $2,105.88 | $1,658.49 | $1,658.49 |
| Basic Shares Outstanding | 455.9K | 13.9K | 6.0K | 6.0K | 5.4K | 4.5K | 4.5K |
| Diluted Shares Outstanding | 455.9K | 13.9K | 6.0K | 6.0K | 5.4K | 4.5K | 4.5K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $33.59B | $29.50B | $5.29M | $5.71M | $8.08M | $10.06M |
| Short-Term Investments | -- | -- | $13.22M | $13.15M | $13.73M | -- |
| **Cash & Short-Term Investments** | $33.59B | $29.50B | $18.50M | $18.86M | $21.80M | $10.06M |
| Accounts Receivable, Net | $13.01B | $12.91B | $11.01M | $15.18M | $15.57M | $10.87M |
| Inventory | $2.19B | $1.74B | $3.34M | $2.21M | $2.46M | $1.91M |
| **Total Current Assets** | $53.60B | $51.64B | $25.27M | $41.51M | $50.48M | $23.28M |
| Property, Plant & Equipment, Net | $3.58B | $3.57B | $3.70M | $4.25M | $4.68M | $4.43M |
| Intangible Assets | $296.8M | $262.9M | $149K | $157K | $149K | $175K |
| **Total Non-Current Assets** | $15.70B | $16.32B | $16.45M | $18.03M | $19.66M | $5.52M |
| **Total Assets** | $69.30B | $67.95B | $41.72M | $59.54M | $70.14M | $28.80M |
| Accounts Payable | $1.67B | $4.91B | $4.59M | $3.08M | $5.31M | $2.69M |
| Short-Term Debt | $9.26B | $5.86B | $5.48M | $3.94M | $4.33M | $2.65M |
| Deferred Revenue (Current) | $40.71M | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $13.17B | $20.31B | $13.75M | $13.10M | $11.21M | $8.00M |
| **Total Non-Current Liabilities** | $0 | $2.14B | $0 | -- | $11.94M | $0 |
| **Total Liabilities** | $13.17B | $22.45B | $13.75M | -- | $23.15M | $8.00M |
| **Total Debt (incl. Leases)** | $9.26B | $5.86B | $5.48M | $3.94M | $4.33M | $2.65M |
| Common Stock | $6.34B | $482.4M | $68K | $68K | $68K | $50K |
| Retained Earnings | -$13.84B | -$10.17B | -$1.44M | $16.32M | $25.06M | $13.74M |
| Accumulated Other Comp. Income | -$1.81B | -$1.11B | -$2.37M | -$1.67M | $2.09M | $895K |
| **Total Stockholders' Equity** | $56.13B | $45.50B | $27.97B | $35.33B | $46.99M | $20.80M |
| Total Equity | $56.13B | $45.50B | $27.97B | $35.33B | $46.99M | $20.80M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $33.59B | $29.50B | $5.29M | $5.71M | $8.08M | $10.06M |
| Short-Term Investments | -- | -- | $13.22M | $13.15M | $13.73M | -- |
| **Cash & Short-Term Investments** | $33.59B | $29.50B | $18.50M | $18.86M | $21.80M | $10.06M |
| Accounts Receivable, Net | $13.01B | $12.91B | $11.01M | $15.18M | $15.57M | $10.87M |
| Inventory | $2.19B | $1.74B | $3.34M | $2.21M | $2.46M | $1.91M |
| **Total Current Assets** | $53.60B | $51.64B | $25.27M | $41.51M | $50.48M | $23.28M |
| Property, Plant & Equipment, Net | $3.58B | $3.57B | $3.70M | $4.25M | $4.68M | $4.43M |
| Intangible Assets | $296.8M | $262.9M | $149K | $157K | $149K | $175K |
| **Total Non-Current Assets** | $15.70B | $16.32B | $16.45M | $18.03M | $19.66M | $5.52M |
| **Total Assets** | $69.30B | $67.95B | $41.72M | $59.54M | $70.14M | $28.80M |
| Accounts Payable | $1.67B | $4.91B | $4.59M | $3.08M | $5.31M | $2.69M |
| Short-Term Debt | $9.26B | $5.86B | $5.48M | $3.94M | $4.33M | $2.65M |
| Deferred Revenue (Current) | $40.71M | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $13.17B | $20.31B | $13.75M | $13.10M | $11.21M | $8.00M |
| **Total Non-Current Liabilities** | $0 | $2.14B | $0 | -- | $11.94M | $0 |
| **Total Liabilities** | $13.17B | $22.45B | $13.75M | -- | $23.15M | $8.00M |
| **Total Debt (incl. Leases)** | $9.26B | $5.86B | $5.48M | $3.94M | $4.33M | $2.65M |
| Common Stock | $6.34B | $482.4M | $68K | $68K | $68K | $50K |
| Retained Earnings | -$13.84B | -$10.17B | -$1.44M | $16.32M | $25.06M | $13.74M |
| Accumulated Other Comp. Income | -$1.81B | -$1.11B | -$2.37M | -$1.67M | $2.09M | $895K |
| **Total Stockholders' Equity** | $56.13B | $45.50B | $27.97B | $35.33B | $46.99M | $20.80M |
| Total Equity | $56.13B | $45.50B | $27.97B | $35.33B | $46.99M | $20.80M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.67B | -$8.73B | -$6.58B | -$8.74M | $11.32M | $7.56M | $7.55M |
| Depreciation & Amortization | $517.4M | $485.7M | $508.8M | $534K | $447K | $410K | $418K |
| Change in Receivables | -$169.0M | -$1.55B | $4.72B | -$1.53M | -$3.87M | -$4.11M | $665K |
| Change in Inventory | -$474.6M | $1.64B | -$1.18B | $17K | -$452K | $889K | $5.59M |
| Change in Payables | -$3.13B | $143.7M | $1.64B | -$1.92M | $2.46M | $639K | -$924K |
| **Operating Cash Flow** | -$5.05B | -$9.51B | $1.12B | -$1.30M | -$2.06M | $6.12M | $13.20M |
| Capital Expenditure | -$266.8M | -$208.3M | -$44.17M | -$94K | -$445K | -$52K | -$86K |
| **Free Cash Flow** | -$5.32B | -$9.72B | $1.07B | -$1.40M | -$2.50M | $6.06M | $13.12M |
| **Investing Cash Flow** | -$341.8M | -$361.3M | -$44.17M | -$3.91M | -$27.06M | -$52K | -$86K |
| Common Stock Issued | $15.00B | $25.00B | -- | -- | -- | -- | -- |
| Dividends Paid | -- | -- | -- | -- | -- | -- | -$16.00M |
| **Financing Cash Flow** | $9.73B | $33.95B | -$1.39B | $3.32M | $26.58M | $470K | -$16.00M |
| **Net Change in Cash** | $4.09B | $24.21B | -$426.2M | -$2.37M | -$1.98M | $6.88M | -$3.01M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 35.3% | 26.4% | 31.9% | 54.5% | 52.8% | 45.9% | 40.3% |
| **Operating Margin** | -16.3% | -34.8% | -12.3% | -17.5% | 28.3% | 33.4% | 29.4% |
| **Net Profit Margin** | -20.6% | -37.9% | -20.4% | -19.7% | 23.6% | 24.6% | 22.7% |
| Return on Equity (ROE) | -6.5% | -19.2% | -23.5% | 0.0% | 24.1% | 36.3% | -- |
| Return on Assets (ROA) | -5.3% | -12.8% | -15772.6% | -13.3% | 16.1% | 26.2% | -- |
| Current Ratio | 4.07x | 2.54x | 1.84x | 3.17x | 4.50x | 2.91x | -- |
| Quick Ratio | 3.90x | 2.46x | 1.59x | 3.00x | 4.28x | 2.67x | -- |
| Debt to Equity | 0.16x | 0.13x | 0.00x | 0.00x | 0.09x | 0.13x | -- |
| **Revenue Growth (YoY)** | -22.4% | -28.7% | +80383.8% | -16.3% | +56.3% | -7.6% | -- |
| Gross Profit Growth (YoY) | +3.8% | -41.1% | +47019.7% | -13.6% | +79.7% | +5.1% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -151.7% | +32.6% | +5.1% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -169.9% | +49.8% | +0.1% | -- |
| EPS Growth (YoY) | -- | -- | -- | -162.2% | +27.0% | 0.0% | -- |
| Operating Cash Flow Growth (YoY) | -- | -951.3% | -- | -- | -133.6% | -53.7% | -- |
| Free Cash Flow Growth (YoY) | -- | -1005.7% | -- | -- | -141.2% | -53.8% | -- |
| 5Y Revenue / Share Growth | +478.5% | +22468.9% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -583.2% | -37743.6% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
